1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Organon & Co.

Organon & Co.

OGN
Organon & Co.US flagNew York Stock Exchange
13.44
USD
-0.01
- -
3.53BMarket Cap

Income Statement (USD)

MCPAPIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
9,777
7,777
6,532
6,304
6,174
6,263
6,403
6,216
+ Sales & Services Revenue
9,777
7,777
6,532
6,304
6,174
6,263
6,403
6,216
- Cost of Revenue
4,693
2,274
2,119
2,382
2,294
2,515
2,688
2,903
+ Cost of Goods & Services
4,693
2,274
2,119
2,382
2,294
2,515
2,688
2,903
Gross Profit
5,084
5,503
4,413
3,922
3,880
3,748
3,715
3,313
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
2,378
1,663
1,566
2,007
2,175
2,421
2,229
2,087
+ Selling, General & Admin
2,013
1,443
1,356
1,668
1,704
1,893
1,760
1,721
+ Research & Development
365
220
210
339
471
528
469
366
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
2,706
3,840
2,847
1,915
1,705
1,327
1,486
1,226
- Non-Operating (Income) Loss
-23
144
95
386
583
654
679
801
+ Interest Expense, Net
- -
- -
- -
258
422
527
520
504
+ Interest Expense
- -
- -
- -
258
422
527
520
504
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-23
144
95
128
161
127
159
297
Pretax Income
2,729
3,696
2,752
1,529
1,122
673
807
425
- Income Tax Expense (Benefit)
576
390
496
178
205
-350
-57
238
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
2,153
3,306
2,256
1,351
917
1,023
864
187
- Net Extraordinary Losses (Gains)
- -
88
96
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
-88
-96
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
176
192
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
2,153
3,218
2,160
1,351
917
1,023
864
187
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
2,153
3,218
2,160
1,351
917
1,023
864
187
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
2,153
3,218
2,160
1,351
917
1,023
864
187
EBIT
2,706
3,840
2,847
1,915
1,705
1,327
1,486
1,226
EBITDA
4,379
4,173
2,989
2,110
1,917
1,563
1,763
1,587
EBITDA Margin (%)
44.79
53.66
45.76
33.47
31.05
24.96
27.53
25.53
EBITA
2,706
3,840
2,847
1,915
1,705
1,327
1,486
1,226
Gross Margin (%)
52
70.76
67.56
62.21
62.84
59.84
58.02
53.3
Operating Margin (%)
27.68
49.38
43.59
30.38
27.62
21.19
23.21
19.72
Profit Margin (%)
22.02
41.38
33.07
21.43
14.85
16.33
13.49
3.01
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
0.57
1.14
1.15
1.16
0.34
Depreciation Expense
1,673
333
142
195
212
236
277
361
Basic Weighted Avg Shares
253
253
253
254
254
255
257
259
Basic EPS, GAAP
8.51
12.71
8.53
5.33
3.61
4.01
3.36
0.72
Basic EPS from Cont Ops
8.51
13.06
8.91
5.33
3.61
4.01
3.36
0.72
Diluted Weighted Avg Shares
253
253
253
254
255
256
259
261
Diluted EPS, GAAP
8.51
12.71
8.53
5.31
3.59
3.99
3.33
0.72
Diluted EPS from Cont Ops
8.51
13.06
8.91
5.31
3.59
3.99
3.33
0.72

Balance Sheet (USD)

MCPAPIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
3,955
3,567
3,760
3,931
4,508
4,348
4,352
+ Cash, Cash Equivalents & STI
- -
319
12
737
706
693
675
574
+ Cash & Cash Equivalents
- -
319
12
737
706
693
675
574
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
1,487
1,038
1,382
1,475
1,744
1,358
1,331
+ Accounts Receivable, Net
- -
1,474
1,038
1,382
1,475
1,744
1,358
1,331
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
13
- -
- -
- -
- -
- -
- -
+ Inventories
- -
1,071
913
915
1,003
1,315
1,321
1,406
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
1,071
913
915
1,003
1,315
1,321
1,406
+ Other ST Assets
- -
1,078
1,604
726
747
756
994
1,041
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
6,593
6,542
6,921
7,024
7,550
8,753
8,515
+ Property, Plant & Equip, Net
- -
680
984
973
1,018
1,183
1,168
1,303
+ Property, Plant & Equip
- -
1,356
1,804
1,855
1,920
2,200
2,228
2,542
- Accumulated Depreciation
- -
676
820
882
902
1,017
1,060
1,239
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
5,913
5,558
5,948
6,006
6,367
7,585
7,212
+ Total Intangible Assets
- -
5,172
5,106
5,254
5,252
5,136
6,094
5,283
+ Goodwill
- -
4,603
4,603
4,603
4,603
4,603
4,680
4,153
+ Other Intangible Assets
- -
569
503
651
649
533
1,414
1,130
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
741
452
694
754
1,231
1,491
1,929
Total Assets
- -
10,548
10,109
10,681
10,955
12,058
13,101
12,867
+ Payables & Accruals
- -
1,307
1,206
2,588
2,504
2,909
2,698
2,372
+ Accounts Payable
- -
258
259
1,382
1,132
1,314
1,153
952
+ Accrued Taxes
- -
242
288
185
184
206
134
85
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
807
659
1,021
1,188
1,389
1,411
1,335
+ ST Debt
- -
34
1,339
9
8
9
20
16
+ ST Borrowings
- -
34
1,339
9
8
9
20
16
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
128
- -
- -
- -
- -
2
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
128
- -
- -
- -
- -
2
Total Current Liabilities
- -
1,341
2,673
2,597
2,512
2,918
2,718
2,390
+ LT Debt
- -
70
- -
9,125
8,905
8,751
8,860
8,628
+ LT Borrowings
- -
70
- -
9,125
8,905
8,751
8,860
8,628
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
2,102
1,950
467
430
459
1,051
1,097
+ Accrued Liabilities
- -
139
128
4
19
47
74
57
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
1,963
1,822
463
411
412
977
1,040
Total Noncurrent Liabilities
- -
2,172
1,950
9,592
9,335
9,210
9,911
9,725
Total Liabilities
- -
3,513
4,623
12,189
11,847
12,128
12,629
12,115
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
- -
3
3
28
111
170
+ Common Stock
- -
- -
- -
3
3
3
3
3
+ Additional Paid in Capital
- -
- -
- -
- -
- -
25
108
167
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
- -
- -
-998
-331
443
1,010
1,109
+ Other Equity
- -
-914
-622
-513
-564
-541
-649
-527
Equity Before Minority Interest
- -
7,035
5,486
-1,508
-892
-70
472
752
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
7,035
5,486
-1,508
-892
-70
472
752
Total Liabilities & Equity
- -
10,548
10,109
10,681
10,955
12,058
13,101
12,867
Shares Outstanding
- -
253
253
254
254
256
258
260
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
-215
1,327
8,397
8,207
8,067
8,205
8,070
Net Debt to Equity
- -
-3.06
24.19
-556.83
-920.07
-11,524.29
1,738.35
1,073.14
Tangible Common Equity Ratio
- -
34.65
7.6
-124.6
-107.73
-75.21
-80.23
-59.74
Current Ratio
- -
2.95
1.33
1.45
1.56
1.54
1.6
1.82
Cash Conversion Cycle
- -
106.47
192.94
84.49
44.43
104.1
100.26
121.82

Cash Flow Statement (USD)

MCPAPIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
2,153
3,306
2,256
1,351
917
1,023
864
187
+ Depreciation & Amortization
1,673
333
142
195
212
236
277
361
+ Non-Cash Items
35
53
3
-88
181
-305
76
399
+ Stock-Based Compensation
56
41
40
59
75
101
105
77
+ Deferred Income Taxes
37
12
-32
-288
-18
-485
-160
63
+ Asset Impairment Charge
- -
- -
- -
7
9
- -
- -
310
+ Other Non-Cash Adj
-58
- -
-5
134
115
79
131
-51
+ Chg in Non-Cash Work Cap
-174
-672
-117
702
-452
-155
-278
-247
+ (Inc) Dec in Accts Receiv
250
200
13
-277
-123
-212
383
79
+ (Inc) Dec in Inventories
44
-91
34
-138
-220
-230
-131
-13
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
-316
-711
-69
873
-58
281
-323
-420
+ Inc (Dec) in Other
-152
-70
-95
244
-51
6
-207
107
+ Net Cash From Disc Ops
- -
-253
-97
298
- -
- -
- -
- -
Cash from Operating Activities
3,687
2,767
2,187
2,458
858
799
939
700
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
32
4
5
7
7
1
4
1
+ Disp of Fixed Prod Assets
32
4
5
7
7
1
4
1
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
-296
-231
-10
-176
-154
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
-296
-231
-10
-176
-154
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
- -
- -
- -
- -
+ Increase in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
-166
-75
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
-166
-75
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
-101
-106
-263
-548
-196
-251
-175
-162
+ Net Cash From Disc Ops
- -
-14
-8
-356
- -
- -
- -
- -
Cash from Investing Activities
-69
-102
-258
-837
-420
-260
-513
-390
+ Dividends Paid
- -
- -
- -
-145
-290
-294
-297
-88
+ Net Cash From Debt
59
- -
1,512
7,846
-108
-258
-11
-458
+ Cash From Debt
59
- -
1,512
9,470
- -
80
1,186
1,055
+ Repayments of Debt
- -
- -
- -
-1,624
-108
-338
-1,197
-1,513
+ Other Financing Activities
-4,223
-2,621
-3,687
-8,678
-35
-17
-60
-15
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
-4,164
-2,621
-2,175
-977
-433
-569
-368
-561
Effect of Foreign Exchange Rates
19
31
-3
23
-36
17
-76
150
Net Changes in Cash
-546
44
-246
644
5
-30
58
-251
EBITDA
4,379
4,173
2,989
2,110
1,917
1,563
1,763
1,587
EBITDA Margin (%)
44.79
53.66
45.76
33.47
31.05
24.96
27.53
25.53
Free Cash Flow
3,687
2,767
2,187
2,162
627
789
763
546
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
166
75
Free Cash Flow to Firm
3,687
2,767
2,187
2,390
972
- -
- -
768
Free Cash Flow to Equity
- -
2,771
3,704
10,311
757
542
932
243
Free Cash Flow per Basic Share
14.57
10.93
8.64
8.53
2.47
3.09
2.97
2.1
Price/Free Cash Flow
- -
- -
- -
2.81
6.54
4.57
3.47
2.19
Cash Flow to Net Income
1.71
0.86
1.01
1.82
0.94
0.78
1.09
3.74
Capital Expenditures
- -
- -
- -
-296
-231
-10
-176
-154